Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

EBV Dictates Lower Tumor Neoepitopes Scores and Intra-Tumoral Repertoire Diversity in NHL from Immuno-Compromized Patients

Marine Baron, Karim Labreche, Amira Bouzidi, Marianne Veyri, Nathalie Désiré, Véronique Leblond, Florence Coulet, Pierre-Yves Boelle, Fatou Seck Thiam, Damien Roos-Weil, Frédéric Charlotte, Frederic Davi, Elsa Poullot, Alice Rousseau, Corinne Haioun, Jean-Philippe Spano, Brigitte Autran, Choquet Sylvain, Amélie Guihot

Blood (2022) 140 (Supplement 1): 758–759.

https://doi.org/10.1182/blood-2022-162321

Published: 2022

Journal Articles

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Fleur Cohen Aubart, Damien Roos-Weil, Marine Armand, Alice Marceau-Renaut, Jean-François Emile, Nicolas Duployez, Frédéric Charlotte, Stéphanie Poulain, Raphael Lhote, Zofia Hélias-Rodzewicz, Véronique Della-Valle, Olivier Bernard, Karim Maloum, Florence Nguyen-Khac, Jean Donadieu, Zahir Amoura, Omar Abdel-Wahab, Julien Haroche

Blood (2021) 137 (4): 485–492.

https://doi.org/10.1182/blood.2020005101

Published: 2021

Includes: Supplemental data

Journal Articles

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Fleur Cohen-Aubart, MD PhD, Ahmed Idbaih, MD PhD, Damien Galanaud, MD PhD, Bruno Law-Ye, MD, Jean-François Emile, MD PhD, Frédéric Charlotte, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Julien Haroche

Blood (2019) 134 (Supplement_1): 4272.

https://doi.org/10.1182/blood-2019-130606

Published: 2019

Journal Articles

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Frédéric Charlotte, MD, Fleur Cohen-Aubart, MD PhD, Levi-Dan Azoulay, MD, Jean Donadieu, MD PhD, Jean-François Emile, MD PhD, Zahir Amoura, MD, Julien Haroche

Blood (2018) 132 (Supplement 1): 4380.

https://doi.org/10.1182/blood-2018-99-114031

Published: 2018

Journal Articles

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Oussama Abla, Eric Jacobsen, Jennifer Picarsic, Zdenka Krenova, Ronald Jaffe, Jean-Francois Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen-Aubart, Carlos Rodriguez-Galindo, Carl Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond

Blood (2018) 131 (26): 2877–2890.

https://doi.org/10.1182/blood-2018-03-839753

Published: 2018

Journal Articles

Mast Cell Density and Its Clinical Relevance in Waldenstrom's Macroglobulinemia

Richard Lemal, MD, Stephanie Poulain, MD PhD, Albane Ledoux Pilon, MD, Lauren Veronese, MD PhD, Andrei Tchirkov, MD PhD, Benjamin Lebecque, Jacques-Olivier Bay, MD PhD, Frederic Charlotte, MD, Marc G. Berger, MD PhD, Catherine Godfraind, MD PhD, Loic Ysebaert, MD PhD, Frederic Davi, Veronique Leblond, Olivier Hermine, MD PhD, Romain Guieze, MD PhD, Franck Pages, MD PhD, Olivier Tournilhac, MD PhD

Blood (2017) 130 (Supplement 1): 4028.

https://doi.org/10.1182/blood.V130.Suppl_1.4028.4028

Published: 2017

Journal Articles

Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group

Danielle Canioni, MD, Laure Joseph, MD, Bettina Fabiani, MD, Catherine Chassagne-Clément, MD, Peggy Dartigues-Cuillères, MD, Frederic Charlotte, MD, Pauline Brice, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Anne Sonet, MD, Gilles Salles, MD PhD, Luc Xerri, MD PhD

Blood (2017) 130 (Supplement 1): 1508.

https://doi.org/10.1182/blood.V130.Suppl_1.1508.1508

Published: 2017

Journal Articles

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

Fleur Cohen Aubart, Jean-François Emile, Fabrice Carrat, Frédéric Charlotte, Neila Benameur, Jean Donadieu, Philippe Maksud, Ahmed Idbaih, Stéphane Barete, Khê Hoang-Xuan, Zahir Amoura, Julien Haroche

Blood (2017) 130 (11): 1377–1380.

https://doi.org/10.1182/blood-2017-03-771873

Published: 2017

Includes: Supplemental data

Journal Articles

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Blood (2017) 130 (8): 1007–1013.

https://doi.org/10.1182/blood-2017-01-761718

Published: 2017

Includes: Supplemental data

Journal Articles

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Blood (2017) 130 (2): 176–180.

https://doi.org/10.1182/blood-2016-12-757377

Published: 2017

Includes: Supplemental data

Journal Articles

Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells

Mathieu Leclerc, Sina Naserian, Caroline Pilon, Allan Thiolat, Gaëlle H. Martin, Charlotte Pouchy, Claude Dominique, Yazid Belkacemi, Frédéric Charlotte, Sébastien Maury, Benoit L. Salomon, José L. Cohen

Blood (2016) 128 (12): 1651–1659.

https://doi.org/10.1182/blood-2016-02-700849

Published: 2016

Includes: Supplemental data

Journal Articles

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Blood (2016) 127 (22): 2672–2681.

https://doi.org/10.1182/blood-2016-01-690636

Published: 2016

Includes: Supplemental data

Journal Articles

Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease

Fleur Cohen-Aubart, Philippe Maksud, David Saadoun, Aurélie Drier, Frédéric Charlotte, Philippe Cluzel, Zahir Amoura, Julien Haroche

Blood (2016) 127 (11): 1509–1512.

https://doi.org/10.1182/blood-2015-09-672667

Published: 2016

Journal Articles

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Blood (2015) 126 (23): 1479.

https://doi.org/10.1182/blood.V126.23.1479.1479

Published: 2015

Journal Articles

Auto-Immune Origin of B Cells from HCV-Associated Lymphoma

Marine Armand, Myriam Boudjoghra, Aliki Xochelli, Danielle Canioni, Magali Le Garff Tavernier, Monica Colombo, Pascaline Rabiega, Thierry Molina, Frederic Charlotte, Jean-Marie Michot, Claude Lesty, Fabrice Carrat, Manlio Ferrarini, Kostas Stamatopoulos, Caroline Besson, Olivier Hermine, Frederic Davi

Blood (2015) 126 (23): 1464.

https://doi.org/10.1182/blood.V126.23.1464.1464

Published: 2015

Journal Articles

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Blood (2014) 124 (19): 3016–3019.

https://doi.org/10.1182/blood-2014-04-570937

Published: 2014

Includes: Supplemental data

Journal Articles

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAF V600E mutation

Blood (2014) 124 (7): 1119–1126.

https://doi.org/10.1182/blood-2013-12-543793

Published: 2014

Journal Articles

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen-Aubart, Jean-François Emile, Laurent Arnaud, Philippe Maksud, Frédéric Charlotte, Philippe Cluzel, Aurélie Drier, Baptiste Hervier, Neïla Benameur, Sophie Besnard, Jean Donadieu, Zahir Amoura

Blood (2013) 121 (9): 1495–1500.

https://doi.org/10.1182/blood-2012-07-446286

Published: 2013

Includes: Supplemental data

Journal Articles

Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe

Blood (2012) 120 (21): 1607.

https://doi.org/10.1182/blood.V120.21.1607.1607

Published: 2012

Journal Articles

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Blood (2012) 120 (13): 2700–2703.

https://doi.org/10.1182/blood-2012-05-430140

Published: 2012

NARROW

EBV Dictates Lower Tumor Neoepitopes Scores and Intra-Tumoral Repertoire Diversity in NHL from Immuno-Compromized Patients

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Mast Cell Density and Its Clinical Relevance in Waldenstrom's Macroglobulinemia

Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Auto-Immune Origin of B Cells from HCV-Associated Lymphoma

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAF V600E mutation

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only